On August 28, 2025, the 2025 BioCloud Conference opened at Jing An Shangri-La, Shanghai, under the theme "China's Pharmaceutical Industry From a Global Perspective." The conference brought together industry professionals and leading companies to discuss the current state and development trends of the industry around three keywords: insight, interpretation, and intelligence, jointly exploring the path of transformation.
MeDomino was invited to attend the conference. Founder and CEO Lu Wenqing delivered a sharing titled "Hot AI, Cool Thinking," proposing that enterprises need to build a mindset of data accumulation, apply AI insights where they are strongest, plan content from an overall perspective, and return to the essence of business to help break through digital transformation challenges.
MeDomino also set up a dedicated booth on site, creating a bridge for industry peers to communicate, collaborate, and seek new opportunities for development.
As China's pharmaceutical industry accelerates its upgrade, it will also create broader room for AI development. In the future, AI will be more than a technical tool. It will become a new brain for the healthcare industry, a strategic engine driving healthcare transformation toward greater precision, accessibility, efficiency, and human-centered care. Beyond healthcare, we believe AI intelligence will also penetrate scientific research, education, elderly care, consumer services, public welfare, and many other aspects of daily life in the near future.
